文献速递肺外科

慢性阿片类药物使用者接受肺叶切除术的围术期结局

Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-09-27

倾向匹配后,慢性使用者30天和90天死亡率近2倍于非慢性使用者,住院时间和费用增加,90天再入院风险升高(OR 1.72)。

要点

  • 慢性阿片使用者肺叶切除术后30天和90天死亡率近2倍于非慢性使用者
  • 慢性使用者住院时间中位数7天 vs 6天,平均费用增加$12,526
  • 慢性使用者90天再入院风险升高(OR 1.72),主要为感染、肾脏和肺部原因

核心结论

  • 慢性阿片使用者肺叶切除术后死亡、住院时间、费用和再入院风险显著升高,属高危人群。

主要发现

  • 倾向匹配后慢性使用者30天和90天死亡率近2倍于非慢性使用者。
  • 慢性使用者住院时间中位数7天 vs 6天,平均费用增加$12,526。
  • 多变量分析显示间断使用和慢性使用与90天再入院风险升高相关(OR 1.35, 95%CI 1.07-1.71;OR 1.72, 95%CI 1.40-2.12),主要为感染、肾脏和肺部原因。

关键数值与推荐

  • 慢性阿片使用者定义:术前一年阿片累计供应>120天。
  • 90天再入院OR:间断使用1.35(95%CI 1.07-1.71),慢性使用1.72(95%CI 1.40-2.12)。

临床怎么用

  • 术前应识别慢性阿片使用者,将其视为肺叶切除术后并发症和再入院高危人群,加强围术期管理。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to identify whether chronic opioid users are at increased risk for complications or hospital readmission following lobectomy for non-small cell lung cancer. METHODS: The National Cancer Institute Surveillance, Epidemiology, and End Results-Medicare database was queried to identify patients older than age 65 years who received a lobectomy for non-small cell lung cancer. Chronic opioid users were identified through Medicare Part D records and were defined as those with >120 cumulative days of opioid supply for the year before surgery. A systematic 1:2 propensity matching was performed among chronic opioid users. RESULTS: Six thousand four hundred thirty-seven patients were identified, among whom 3627 (56%) were opioid naïve, 1866 (29%) were intermittent opioid users, and 944 (15%) were chronic opioid users. After propensity matching, 30-day mortality and 90-day mortality were nearly 2-fold higher among chronic opioid users compared with nonchronic users. In addition, length of stay and hospital charges were increased among chronic opioid users (median, 6 vs 7 days and mean increase, $12,526, respectively). Multivariable analysis revealed that intermittent opioid users and chronic opioid users were associated with an increased risk of 90-day hospital readmission compared with opioid-naïve patients (odds ratio, 1.35; 95% confidence interval, 1.07-1.71 and odds ratio, 1.72; 95% confidence interval, 1.40-2.12, respectively), predominantly burdened by infectious, renal, and pulmonary causes. CONCLUSIONS: Patients who chronically use opioids before lobectomy represent high-risk patients. The risk of 30- and 90-day mortality, length of stay, hospital charges, and 90-day readmission after lobectomy among chronic opioid users are substantially elevated.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nelson DB, Niu J, Mitchell KG, et al. Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019. PMID: 33003262. doi:10.1016/j.jtcvs.2019.09.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。